Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9542 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9494 |
High Similarity |
NPD6166 |
Phase 2 |
0.9494 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9494 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9477 |
High Similarity |
NPD1934 |
Approved |
0.9097 |
High Similarity |
NPD4380 |
Phase 2 |
0.9051 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.9045 |
High Similarity |
NPD2801 |
Approved |
0.9024 |
High Similarity |
NPD7074 |
Phase 3 |
0.8963 |
High Similarity |
NPD7054 |
Approved |
0.8931 |
High Similarity |
NPD3882 |
Suspended |
0.8909 |
High Similarity |
NPD7472 |
Approved |
0.8902 |
High Similarity |
NPD3818 |
Discontinued |
0.8882 |
High Similarity |
NPD5494 |
Approved |
0.8848 |
High Similarity |
NPD5844 |
Phase 1 |
0.8831 |
High Similarity |
NPD1511 |
Approved |
0.8758 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD7075 |
Discontinued |
0.875 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD6797 |
Phase 2 |
0.8718 |
High Similarity |
NPD1512 |
Approved |
0.869 |
High Similarity |
NPD7251 |
Discontinued |
0.8688 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD7411 |
Suspended |
0.8654 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD7808 |
Phase 3 |
0.8639 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD3817 |
Phase 2 |
0.8631 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD1549 |
Phase 2 |
0.8598 |
High Similarity |
NPD6959 |
Discontinued |
0.8562 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8545 |
High Similarity |
NPD6232 |
Discontinued |
0.8512 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD6801 |
Discontinued |
0.8503 |
High Similarity |
NPD7473 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8457 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8377 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8232 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD5402 |
Approved |
0.817 |
Intermediate Similarity |
NPD1240 |
Approved |
0.817 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8101 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8065 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8052 |
Intermediate Similarity |
NPD943 |
Approved |
0.8049 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8036 |
Intermediate Similarity |
NPD919 |
Approved |
0.8034 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7963 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7953 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7853 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7845 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7816 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7772 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7765 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7711 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7702 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7669 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7658 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7651 |
Intermediate Similarity |
NPD920 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD37 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7604 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7602 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7598 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7553 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7553 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7542 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7531 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD2344 |
Approved |
0.753 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7516 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD9494 |
Approved |
0.75 |
Intermediate Similarity |
NPD7584 |
Approved |
0.75 |
Intermediate Similarity |
NPD6651 |
Approved |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7344 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7288 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7288 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7287 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7173 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7158 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7107
|
Intermediate Similarity |
NPD7585 |
Approved |